Ambev S.A.
NYSE:ABEVBeverages - Alcoholic
-$0.02 today
- Market cap
- $42.89B
- Beta
- 0.27
- P/E (TTM)
- 16.2
- EPS (TTM)
- $1.00
- Dividend yield
- 9.76%
Volume 11.24M
Average 27.73M
ABEV EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
Ambev S.A.NYSE: ABEV
EBITDA · Q2 FY2026 · quarter ended Jun 2026
EBITDA growth accelerates
Q2 FY2026 EBITDA of R$6.41B rose 12.7% year over year, ahead of the +1.0% change in trailing-twelve-month EBITDA. Sequentially, it fell 10.4% from the prior quarter. Over 3 fiscal years it compounded at +7.9% a year.
Context
- EBITDA amounted to 32.8% of revenue in FY2025, up 0.4 pp from a year earlier.
- EBITDA increased in 2 of the last 3 fiscal years.
What to watch
Whether EBITDA reaches the consensus estimate from 9 analysts of R$26.88B (-7.2%) for the fiscal year ending Dec 2026, a slowdown from the -0.1% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterJun 2026
- R$6.41B-10.4% QoQ
- Last fiscal yearDec 2025
- R$28.97B-0.1% YoY
- LTMJun 2026
- R$29.69B+1.0% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +12.7% | -9.4% | -22.0 pp |
| 1 year | -0.1% | -7.2% | -7.1 pp |
| 3-year CAGR | +7.9% | -0.1% | -8.0 pp |
| 5-year CAGR | +4.2% | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
BRL · from the income statement
- Latest · FY2025
- 28.97B BRL
- Year-over-year change
- -0.1%
- 4-year CAGR
- +8.4%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 28.97B | -0.1% |
| FY2024 | 2024-12-31 | 29.01B | +19.5% |
| FY2023 | 2023-12-31 | 24.27B | +5.1% |
| FY2022 | 2022-12-31 | 23.08B | +10.0% |
| FY2021 | 2021-12-31 | 20.99B | — |
EBITDA vs competitors
How ABEV compares with its peers on the latest reported figures
- Peers report in different currencies, so EBITDA is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +1.0% is the 3rd highest of 5, against a peer median of -2.4%.
- EBITDA amounts to 33.6% of revenue for ABEV, versus a peer median of 16.6%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | CLP 361.5B CLP | -7.5% | -1.0% | 12.4% | |
| LTM Jun 2026 | R$29.69B BRL | +1.0% | +7.9% | 33.6% | |
| FY2025 | $20.84B USD | +2.7% | +3.2% | 35.1% | |
| LTM Jun 2026 | $7.32B USD | — | -59.2% | 15.1% | |
| LTM Aug 2026 | $3.25B USD | +27.2% | +39.3% | 35.2% | |
| LTM Jun 2026 | -$1.84B USD | -175.4% | — | 16.6% | |
| Peer median (excluding ABEV) | — | -2.4% | +1.1% | 16.6% | |
Competitors are the stored peer set for ABEV. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 72.85B | 79.71B | 79.74B | 89.45B | 88.24B |
| Cost of Revenue | 35.66B | 40.42B | 39.29B | 43.62B | 42.86B |
| Gross Profit | 37.19B | 39.29B | 40.45B | 45.84B | 45.38B |
| Gross Margin | 51.1% | 49.3% | 50.7% | 51.2% | 51.4% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 21.85B | 23.97B | 23.44B | 26.39B | 25.14B |
| Operating Expenses | 20.11B | 21.6B | 21.61B | 24.04B | 23.06B |
| Depreciation & Amortization | 5.4B | 5.96B | 6.42B | 7.13B | 6.83B |
| EBITDA | 20.99B | 23.08B | 24.27B | 29.01B | 28.97B |
| EBITDA Margin | 28.8% | 29.0% | 30.4% | 32.4% | 32.8% |
| Operating Income | 17.08B | 17.69B | 18.83B | 21.8B | 22.32B |
| Operating Margin | 23.4% | 22.2% | 23.6% | 24.4% | 25.3% |
| Interest Income | 1.14B | 419.72M | 417.55M | 1.62B | 1.4B |
| Interest Expense | 1.43B | 596.1M | 578.43M | 2.4B | 2.72B |
| Other Income / Expenses | (3.32B) | (3.45B) | (3.8B) | (2.31B) | (2.9B) |
| Income Before Tax | 13.76B | 14.24B | 15.04B | 19.49B | 19.42B |
| Pre-Tax Margin | 18.9% | 17.9% | 18.9% | 21.8% | 22.0% |
| Income Tax Expense | 636.6M | (655.6M) | 75.5M | 4.64B | 3.43B |
| Net Income | 12.67B | 14.46B | 14.5B | 14.44B | 15.5B |
| Net Margin | 17.4% | 18.1% | 18.2% | 16.1% | 17.6% |
| EPS (Basic) | 0.81 | 0.92 | 0.92 | 0.92 | 0.99 |
| EPS (Diluted) | 0.80 | 0.91 | 0.92 | 0.91 | 0.99 |
| Weighted Avg Shares | 15.74B | 15.74B | 15.84B | 15.81B | 15.62B |
| Weighted Avg Shares (Diluted) | 15.86B | 15.85B | 15.84B | 15.81B | 15.68B |
Ambev S.A.
NYSE:ABEV
Intrinsic Alpha fair value
Locked
Current Price
$2.70
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.